Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Insiders have been trading these 5 stocks: (($UAL)), (($DVN)), (($DDOG)), (($HIMS)) and (($FUBO)). Here is a breakdown of ...

Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...

The latest health news highlights Britain's stance on the bioethanol industry, Berkshire Hathaway's investment moves, the FTC's probe into Hims & Hers, Scorpion Capital's position on Soleno ...

Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...

Oscar Health has a lot of opportunities with the growth of Health Reimbursement Arrangements. See why OSCR stock is a buy ...

A draft of the Trump administration’s highly anticipated blueprint on health policy takes a softer approach to regulating companies than many had feared, a relief for industry and setback for ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Rescuers in northwest Pakistan pulled 63 more bodies overnight from homes flattened by landslides and flash floods, raising ...

U.S. President Donald Trump spoke to Ukrainian President Volodymyr Zelenskyy after his summit with Russia’s Vladimir Putin in Alaska and also was talking with NATO leaders ...

Bullish flow in Novo Nordisk (NVO), with shares up $1.52, or 2.99%, near $52.48. Options volume roughly in line with average with 102k contracts ...